Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on western diet

被引:104
作者
Ou, JS
Wang, JL
Xu, H
Ou, ZJ
Sorci-Thomas, MG
Jones, DW
Signorino, P
Densmore, JC
Kaul, S
Oldham, KT
Pritchard, KA
机构
[1] Med Coll Wisconsin, CRI, CVC, Dept Surg,Div Pediat Surg, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA
[4] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Div Cardiothorac Surg, Guangzhou, Peoples R China
[5] Guangzhou Med Univ, Affiliated Hosp 1, Dept Med, Div Cardiol, Guangzhou, Peoples R China
[6] Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27109 USA
关键词
cardiovascular diseases; hypercholesterolemia; lipoproteins; nitric oxide synthase; vasodilation;
D O I
10.1161/01.RES.0000190634.60042.cb
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previously we showed L-4F, a novel apolipoprotein A-I (apoA-I) mimetic, improved vasodilation in 2 dissimilar models of vascular disease: hypercholesterolemic LDL receptor-null (Ldlr(-/-)) mice and transgenic sickle cell disease mice. Here we determine the mechanisms by which D-4F improves vasodilation and arterial wall thickness in hypercholesterolemic Ldlr (-/-) mice and Ldlr(-/-)/apoA-I null (apoA-I-/-), double-knockout mice. Ldlr(-/-) and Ldlr (-/-)/apoA-I-/- mice were fed Western diet (WD) with and without D-4F. Oral D-4F restored endothelium- and endothelial NO synthase ( eNOS)- dependent vasodilation in direct relationship to duration of treatments and reduced wall thickness in as little as 2 weeks in vessels with preexisting disease in Ldlr(-)/(-) mice. D-4F had no effect on total or HDL cholesterol concentrations but reduced proinflammatory HDL levels. D-4F had no effect on plasma myeloperoxidase concentrations but reduced myeloperoxidase association with apoA-I as well as 3-nitrotyrosine in apoA-I. D-4F increased endothelium- and eNOS- dependent vasodilation in Ldlr(-/-)/apoA-I-/- mice but did not reduce wall thickness as it had in Ldlr(-/-) mice. Vascular endothelial cells were treated with 22(R)-hydroxycholesterol with and without L-4F. 22(R)-Hydroxycholesterol decreased NO ((NO)-N-center dot) and increased superoxide anion ( O-2(center dot-)) production and increased ATP-binding cassette transporter-1 and collagen expression. L-4F restored (NO)-N-center dot and O-2(center dot-) balance, had little effect on ATP-binding cassette transporter-1 expression, but reduced collagen expression. These data demonstrate that although D-4F restores vascular endothelial cell and eNOS function to increase vasodilation, HDL containing apoA-I, or at least some critical concentration of the antiatherogenic lipoprotein, is required for D-4F to decrease vessel wall thickness.
引用
收藏
页码:1190 / 1197
页数:8
相关论文
共 37 条
[1]   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[2]   Apolipoprotein A-IMilano and apolipoprotein A-IParis exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I [J].
Bielicki, JK ;
Oda, MN .
BIOCHEMISTRY, 2002, 41 (06) :2089-2096
[3]   Increased atherosclerosis in myeloperoxidase-deficient mice [J].
Brennan, ML ;
Anderson, MM ;
Shih, DM ;
Qu, XD ;
Wang, XP ;
Mehta, AC ;
Lim, LL ;
Shi, WB ;
Hazen, SL ;
Jacob, JS ;
Crowley, JR ;
Heinecke, JW ;
Lusis, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (04) :419-430
[4]   Regression or progression - Dependency on vascular nitric oxide [J].
Candipan, RC ;
Wang, BY ;
Buitrago, R ;
Tsao, PS ;
Cooke, JP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :44-50
[5]   LIPIDS AND OXIDIZED LIPIDS IN HUMAN ATHEROSCLEROTIC LESIONS AT DIFFERENT STAGES OF DEVELOPMENT [J].
CARPENTER, KLH ;
TAYLOR, SE ;
VANDERVEEN, C ;
WILLIAMSON, BK ;
BALLANTINE, JA ;
MITCHINSON, MJ .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1256 (02) :141-150
[6]   LOSS OF SELECTIVE ENDOTHELIAL-CELL VASOACTIVE FUNCTIONS CAUSED BY HYPERCHOLESTEROLEMIA IN PIG CORONARY-ARTERIES [J].
COHEN, RA ;
ZITNAY, KM ;
HAUDENSCHILD, CC ;
CUNNINGHAM, LD .
CIRCULATION RESEARCH, 1988, 63 (05) :903-910
[7]   Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response [J].
Feingold, KR ;
Memon, RA ;
Moser, AH ;
Grunfeld, C .
ATHEROSCLEROSIS, 1998, 139 (02) :307-315
[8]   Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide [J].
Gupta, H ;
Dai, LJ ;
Datta, G ;
Garber, DW ;
Grenett, H ;
Li, YB ;
Mishra, V ;
Palgunachari, MN ;
Handattu, S ;
Gianturco, SH ;
Bradley, WA ;
Anantharamaiah, GM ;
White, CR .
CIRCULATION RESEARCH, 2005, 97 (03) :236-243
[9]   Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms [J].
Harada-Shiba, M ;
Kinoshita, M ;
Kamido, H ;
Shimokado, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9681-9687
[10]   Elevated high-density lipoprotein cholesterol levels are protective against plaque progression - A follow-up study of 1952 persons with carotid atherosclerosis - The Tromso study [J].
Johnsen, SH ;
Mathiesen, EB ;
Fosse, E ;
Joakimsen, O ;
Stensland-Bugge, E ;
Njolstad, I ;
Arnesen, E .
CIRCULATION, 2005, 112 (04) :498-504